California genomics company to close Denver office, cut jobs
The closure comes nearly a year after the firm's acquisition of a local company. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 23, 2019 Category: Pharmaceuticals Authors: Jensen Werley Source Type: news

UnitedHealth: We ’re Still Working On Closing DaVita Deal
UnitedHealth Group's Optum unit is still working with regulators to close its acquisition of DaVita Medical Group, a purchase first announced in December of 2017. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 23, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Huge £175m IT deal will cover three prestigious trusts
A major hospital trust has gone to market for a £175m overhaul of its IT systems, with an option to expand into two neighbouring trusts amid merger rumours. (Source: HSJ)
Source: HSJ - May 23, 2019 Category: UK Health Source Type: news

Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer
Drug-resistance dissemination by horizontal gene transfer remains poorly understood at the cellular scale. Using live-cell microscopy, we reveal the dynamics of resistance acquisition by transfer of the Escherichia coli fertility factor–conjugation plasmid encoding the tetracycline-efflux pump TetA. The entry of the single-stranded DNA plasmid into the recipient cell is rapidly followed by complementary-strand synthesis, plasmid-gene expression, and production of TetA. In the presence of translation-inhibiting antibiotics, resistance acquisition depends on the AcrAB-TolC multidrug efflux pump, because it reduces tetr...
Source: ScienceNOW - May 23, 2019 Category: Science Authors: Nolivos, S., Cayron, J., Dedieu, A., Page, A., Delolme, F., Lesterlin, C. Tags: Cell Biology, Microbiology reports Source Type: news

The Robots Are Coming, Are You Ready?
Robotics in medtech are quickly becoming common place as the number of companies in the market continue to grow. On June 12, seasoned veterans of robotic surgery companies will share their thoughts about the state of surgical robotics technology at MD&M East. It’s no secret that for many years Intuitive Surgical has long dominated the surgical robotics market. The Sunnyvale, CA-based company’s name has been synonymous with surgical robotics in medtech. But that is rapidly changing. Johnson & Johnson’s Ethicon subsidiary along with Alphabet’s Ve...
Source: MDDI - May 22, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Business Source Type: news

South Africa: Laying Foundations for Precision Cancer Medicine
[UCT] The recent acquisition of a portfolio of key life sciences patents, promises to push cancer biotechnology research at the University of Cape Town (UCT) to new heights under the leadership of Professor Stefan Barth. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 22, 2019 Category: African Health Source Type: news

Merck acquires Peloton Therapeutics for $1 billion
The acquisition of Peloton, which was seeking to go public last week, brings its lead kidney cancer drug candidate to Merck, strengthening its renal cell carcinoma presence (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - May 21, 2019 Category: Pharmaceuticals Source Type: news

Opioid Suits Loom Over A Walgreens-AmerisourceBergen Deal
AmerisourceBergen's potential exposure in opioid-related litigation figures in Walgreens Boots Alliance potential acquisition of the drug distributor. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 21, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

What J.P. Morgan's $500M acquisition of InstaMed means for Philadelphia
There ’s nothing like a big, half-billion-dollar-plus exit to boost a startup ecosystem. In the last 15 months, the Philadelphia region has seen three. “That’s a big deal for any market,” said Dean Miller, CEO and president of the Philadelphia Alliance for Capital and Technologies. The latest is J.P. Morgan’s more than $500 million acquisition of Center City health care payment tech firm InstaMed. The deal comes about three months after Swiss pharma giant Roche said it agreed to buy… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 21, 2019 Category: Pharmaceuticals Authors: Michelle Caffrey Source Type: news

Seattle's Sana Biotechnology expands with Cambridge lab acquisition
A preclinical gene and cell therapy hoping to be the biotech world ’s new unicorn is expanding in Cambridge after acquiring a Flagship Pioneering company. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 20, 2019 Category: Health Management Authors: Allison DeAngelis Source Type: news

Seattle's Sana Biotechnology expands with Cambridge lab acquisition
A preclinical gene and cell therapy hoping to be the biotech world ’s new unicorn is expanding in Cambridge after acquiring a Flagship Pioneering company. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 20, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

BENEFIT Results Could Contain Spoilers for Monarch ’s Effectiveness
Johnson & Johnson’s Auris Health scored positive preliminary results from a first-in-human study evaluating the Monarch Platform to aid in the diagnosis of peripheral pulmonary lesions. Data from the BENEFIT study was presented at the American Thoracic Society 2019 Conference in Dallas. So far in BENEFIT, Monarch has been used in 24 patients to localize targeted nodules using a combination of direct visualization, navigational guidance and radial endobronchial ultrasound. The primary effectiveness endpoint, successful localization of targeted pulmonary lesions confirmed using a radial endobronchial ul...
Source: MDDI - May 20, 2019 Category: Medical Devices Authors: Omar Ford Tags: Digital Health Source Type: news

Medical Center hospital ’s parent files for Chapter 11; could get a new owner
Hospital Acquisition LLC, parent company of LifeCare Health Partners, which operates LifeCare Hospitals of San Antonio, has filed for Chapter 11 bankruptcy protection.   The Plano-based company, which operates a network of hospitals and home health organizations in more than a half-dozen states, filed the petition in the United States Bankruptcy Court for the District of Delaware — less than seven years after reaching an agreement to acquire what was then Li feCare Holdings Inc. in December 2012.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 20, 2019 Category: American Health Authors: W. Scott Bailey Source Type: news

Baptist Health profits soar in Q1
The hospital system made an acquisition of an ambulatory surgery center. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 20, 2019 Category: American Health Authors: Brian Bandell Source Type: news

Analyst: LabCorp ripe for Walgreens acquisition
Raymond James analyst John Ransom this week named two potential targets for Walgreens Boots Alliance: LabCorp and drug wholesaler AmerisourceBergen. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 16, 2019 Category: Health Management Authors: Margaret Moffett Source Type: news

Analyst: LabCorp ripe for Walgreens acquisition
Raymond James analyst John Ransom this week named two potential targets for Walgreens Boots Alliance: LabCorp and drug wholesaler AmerisourceBergen. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2019 Category: Biotechnology Authors: Margaret Moffett Source Type: news

Chester County biopharmaceutical company sold
ESSA Pharma Inc. entered into a definitive agreement Thursday to acquire Realm Therapeutics, a Chester County biopharmaceutical company, in an all-stock transaction valued at $21.5 million. Realm of Malvern, Pa., was focused on developing new therapies to treat skin disorders. The $21.5 million price tag for the company represents a 5% premium over Realm's estimated net cash amount of $20.5 million at the closing of the acquisition. The acquisition is subject to Realm shareholder approval. Under… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 16, 2019 Category: Health Management Authors: John George Source Type: news

Chester County biopharmaceutical company sold
ESSA Pharma Inc. entered into a definitive agreement Thursday to acquire Realm Therapeutics, a Chester County biopharmaceutical company, in an all-stock transaction valued at $21.5 million. Realm of Malvern, Pa., was focused on developing new therapies to treat skin disorders. The $21.5 million price tag for the company represents a 5% premium over Realm's estimated net cash amount of $20.5 million at the closing of the acquisition. The acquisition is subject to Realm shareholder approval. Under… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 16, 2019 Category: Biotechnology Authors: John George Source Type: news

Coppertone acquired for $550 million
Germany company Beiersdorf has announced plans to purchase U.S. sun care brand Coppertone from Bayer for $550 million pending approval by merger authorities, Bloomberg reported. Beiersdorf’s lineup of skin care brands includes Nivea, Eucerin and Aquaphor, with sun care products marketed under the Nivea Sun and Eucerin names. Coppertone had sales of about $213 million in 2018. Bayer said the sale would allow it to focus on its core over-the-counter brands, including a spirin and vitamins, per… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 16, 2019 Category: Pharmaceuticals Authors: Anne Stych Source Type: news

The media has turned against Monsanto, and Bayer is now facing a "snowball effect" of new lawsuits from victims of Roundup (glyphosate) exposure
(Natural News) With the acquisition of Monsanto by Bayer, a German corporation linked to the Third Reich and the chemical murder of Jews during the Holocaust, the U.S. media has now turned against Monsanto. The $2 billion jury award against Monsanto that was just handed down by a California jury has been widely reported by... (Source: NaturalNews.com)
Source: NaturalNews.com - May 16, 2019 Category: Consumer Health News Source Type: news

Initial results from the New Horizons exploration of 2014 MU69, a small Kuiper Belt object
We describe initial results from these encounter observations. MU69 is a bilobed contact binary with a flattened shape, discrete geological units, and noticeable albedo heterogeneity. However, there is little surface color or compositional heterogeneity. No evidence for satellites, rings or other dust structures, a gas coma, or solar wind interactions was detected. MU69’s origin appears consistent with pebble cloud collapse followed by a low-velocity merger of its two lobes. (Source: ScienceNOW)
Source: ScienceNOW - May 16, 2019 Category: Science Authors: Stern, S. A., Weaver, H. A., Spencer, J. R., Olkin, C. B., Gladstone, G. R., Grundy, W. M., Moore, J. M., Cruikshank, D. P., Elliott, H. A., McKinnon, W. B., Parker, J. W., Verbiscer, A. J., Young, L. A., Aguilar, D. A., Albers, J. M., Andert, T., Andrews Tags: Online Only, Planetary Science r-articles Source Type: news

Speculation Mounts About Walgreens Acquisition Targets
Speculation is growing that Walgreens may buy the rest of AmerisourceBergen Corp. or diagnostic testing firm LabCorp. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

Microbe-Hacker Ginkgo Bioworks Pushes Further Into Medicine With Acquisition Of Genome Mining Platform And Antibiotics Discovery Deal With Roche
Gene-hacking unicorn Ginkgo Bioworks pushed further into medicine with the acquisition of Warp Drive Bio's genome mining platform and its antibiotics discovery deal with Roche. " This is a big part of the future of Ginkgo, " CEO Jason Kelly told Forbes. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 15, 2019 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Source Type: news

Abbott and NIH Join Forces to Advance Neuroscience Research
Abbott Laboratories and the National Institutes of Health have formed an alliance to evaluate applications that could help treat chronic pain and progressive movement disorders, like Parkinson’s disease. The collaboration is a part of NIH’s BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements in neuroscience research. The agreement specifically calls for NIH to use the Abbott Park, IL-based company’s neuromodulation technologies for research related to these NIH initiatives to explore their application for chronic p...
Source: MDDI - May 15, 2019 Category: Medical Devices Authors: Omar Ford Tags: R & D Source Type: news

Local device firm gets private equity infusion
One of Memphis' largest medical device companies has gotten an infusion of capital — and sector expertise.  New York-based private equity firm HealthpointCapital LLC has taken a controlling interesting in Memphis-based CrossRoads Extremity Systems. HealthpointCapital focuses its investments on the musculoskeletal sector.  The equity firm will provide access to additional ope rating capital for growth, market expansion, and “bolt-on” acquisitions for further growth.  "CrossRoads' unique… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 14, 2019 Category: Biotechnology Authors: Jason Bolton Source Type: news

Video from ISMRM 2019: Dr. Hedvig Hricak on disruptors in MRI interpretation
MONTREAL - Monday morning's talks on disruptors in MRI came to a close with...Read more on AuntMinnie.comRelated Reading: Video from ISMRM 2019: Dr. Pia Sundgren on diversity and inclusion Video from ISMRM 2019: Mark Griswold on disruptors in MRI visualization Video from ISMRM 2019: Andrew Webb on disruptors to MRI acquisition ISMRM: Charting a course of diversity and inclusion Video from ISMRM 2019: Dr. Daniel Sodickson on MRI disruptors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2019 Category: Radiology Source Type: news

Video from ISMRM 2019: Mark Griswold on disruptors in MRI visualization
MONTREAL - Disruptors in MRI was the topic of the Monday morning sessions at...Read more on AuntMinnie.comRelated Reading: Video from ISMRM 2019: Dr. Hedvig Hricak on disruptors in MRI interpretation Video from ISMRM 2019: Dr. Pia Sundgren on diversity and inclusion Video from ISMRM 2019: Andrew Webb on disruptors to MRI acquisition ISMRM: Charting a course of diversity and inclusion Video from ISMRM 2019: Dr. Daniel Sodickson on MRI disruptors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2019 Category: Radiology Source Type: news

Another Day, Another Medtech Deal
In a month filled with medtech deal news, CrossRoads Extremity Systems reports a merger agreement with HealthpointCapital.  HealthpointCapital will take a controlling interest in the Memphis, TN-based medical device company in exchange for providing access to operating capital for continued organic growth, market expansion, and bolt-on acquisitions. Using advanced technology and materials since its inception in 2014, CrossRoads has differentiated itself in the foot and ankle sector with its Active Stabilization technology. The technology is designed to simultaneously offer enhanced stabi...
Source: MDDI - May 14, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Orthopedics Source Type: news

CrossRoads Extremity Systems and HealthpointCapital Announce Merger Agreement
Investment to support growth of CrossRoads' Active Stabilization® platform MEMPHIS, Tenn., May 14, 2019 -- (Healthcare Sales & Marketing Network) -- CrossRoads® Extremity Systems, a privately held medical device company and leading innovator in... Devices, Orthopaedic, Mergers & Acquisitions CrossRoads Extremity Systems, Active Stabilization, EcoSMART, Instrument Service (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 14, 2019 Category: Pharmaceuticals Source Type: news

Video from ISMRM 2019: Andrew Webb on disruptors to MRI acquisition
MONTREAL - MRI is one of the most powerful technologies in healthcare, but...Read more on AuntMinnie.comRelated Reading: Video from ISMRM 2019: Dr. Hedvig Hricak on disruptors in MRI interpretation Video from ISMRM 2019: Dr. Pia Sundgren on diversity and inclusion Video from ISMRM 2019: Mark Griswold on disruptors in MRI visualization ISMRM: Charting a course of diversity and inclusion Video from ISMRM 2019: Dr. Daniel Sodickson on MRI disruptors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 14, 2019 Category: Radiology Source Type: news

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. ( “Spark”) today announced that Roche and Spark intend to refile on or about 23 May 2019 their respective Premerger Notification and Report Forms under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tende r offer to purchase all of the outstanding shares of common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subje...
Source: Roche Media News - May 14, 2019 Category: Pharmaceuticals Source Type: news

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.
Roche and Spark Therapeutics, Inc. ( “Spark”) today announced that Roche and Spark intend to refile on or about 23 May 2019 their respective Premerger Notification and Report Forms under the Hart-Scott-Rodino Act (the “HSR Act”) in connection with Roche’s pending acquisition of Spark pursuant to its previously announced tende r offer to purchase all of the outstanding shares of common stock (the “Shares”) of Spark for USD 114.50 per Share, net to the seller thereof in cash, without interest and subject to any withholding taxes required by applicable law and upon the terms and subje...
Source: Roche Investor Update - May 14, 2019 Category: Pharmaceuticals Source Type: news

Monsanto Ordered to Pay $2 Billion in Case Tying Weed Killer to Cancer
(SAN FRANCISCO) — A jury on Monday ordered agribusiness giant Monsanto Co. to pay a combined $2.055 billion to a couple claiming that the company’s popular weed killer Roundup Ready caused their cancers. The jury’s verdict is the third such courtroom loss for Monsanto in California since August, but a San Francisco law professor said it’s likely a trial judge or appellate court will significantly reduce the punitive damage award. The state court jury in Oakland concluded that Monsanto’s weed killer caused the non-Hodgkin’s lymphoma Alva Pilliod and Alberta Pilliod each contracted. Jurors...
Source: TIME: Health - May 14, 2019 Category: Consumer Health News Authors: Paul Elias / AP Tags: Uncategorized Business onetime overnight Source Type: news

Beiersdorf to acquire iconic Coppertone & #8482; brand from Bayer
Significant expansion of portfolio will advance Beiersdorf’s leading position as sun care expert / Beiersdorf delivers first major acquisition under its new C.A.R.E.+ strategy / Divestiture enables Bayer to focus on core OTC business (Source: Bayer Company News)
Source: Bayer Company News - May 13, 2019 Category: Pharmaceuticals Source Type: news

13.05.19: Beiersdorf to acquire iconic Coppertone™ brand from Bayer
Beiersdorf to acquire iconic Coppertone™ brand from BayerSignificant expansion of portfolio will advance Beiersdorf's leading position as sun care expert / Beiersdorf delivers first major acquisition under its new C.A.R.E.+ strategy / Divestiture enables Bayer to focus on core OTC businessmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 13, 2019 Category: Pharmaceuticals Source Type: news

Yet Another Significant Acquisition in the Orthopedics Market
Tis the season for M&A in the orthopedics market. This time out Medtronic is acquiring Titan Spine for an undisclosed sum. Mequon, WI-based Titan Spine markets a full line of Endoskeleton interbody devices featuring its textured surface in the U.S., Europe, and Australia through its sales force and a network of independent distributors. Dublin-based Medtronic said interbody implants are spacers that can be inserted between the vertebrae during spinal fusion surgery to help relieve pressure on nerves and hold the vertebrae in place while fusion occurs. Implant material and shape is thought to play a role in the bone gro...
Source: MDDI - May 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: Orthopedics Source Type: news

Dayton-area senior living community acquired
A Dayton-area senior living community has been acquired by a Marion, Ohio-based organization. United Church Homes recently announced its acquisition of Brookdale Miami Township at 7847 Lois Circle in a news release. The three-story apartment complex has been renamed Trinity Community at Miami Township as a result of the acquisition. The independent living community includes one-bedroom a nd two-bedroom apartments with supportive services available for residents as needed. Trinity Community at… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 10, 2019 Category: Pharmaceuticals Authors: Cecilia Salomone Source Type: news

J & amp;J & #039;s Ethicon Spends $400M for Takeda ’s Fibrin Sealant Patch
Johnson & Johnson’s Ethicon is set to acquire Takeda Pharmaceutical’s Fibrin Sealant Patch for $400 million. The deal is set to close in the second half of 2019. The TachoSil is a surgical patch designed to achieve safe fast and reliable bleeding control. Upon close, about 80 employees will transition to Ethicon. Takeda said net sales for TachoSil were about $155 million for the 2018 fiscal year. Terms for the deal call for Ethicon to acquire the assets and licenses that support the manufacturing, licensing and commercialization of TachoSil, while Takeda maintains ownership of the ma...
Source: MDDI - May 9, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Varian Acquires CyberHeart
Company Adds Technology for Cardiac Radioablation to Its Radiation Medicine Portfolio PALO ALTO, Calif., May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Acquisition Key Highlights The CyberHeart acquisition secures significant intellectu... Devices, Oncology, Mergers & Acquisitions Varian Medical Systems, CyberHeart, cardiac radioablation, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Agreement To Acquire Vertiflex, Inc.
Acquisition of lumbar spinal stenosis treatment to expand portfolio of interventional pain therapies MARLBOROUGH, Mass., May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (NYSE: BSX) today announced that it has entered into a d... Devices, Orthopaedic, Neurosurgery, Mergers & Acquisitions Boston Scientific, Vertiflex, Superion System, lumbar spinal stenosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

LifeCare Hospitals file for Chapter 11 bankruptcy
The Texas-based owner of long-term care hospitals in Pittsburgh and elsewhere filed for Chapter 11 bankruptcy. Hospital Acquisition LLC, parent company of LifeCare Hospitals and 21 other subsidiaries, filed for Chapter 11 bankruptcy protection from creditors on Monday in U.S. Bankruptcy Court in Wilmington, Delaware. The filings included LifeCare Hospitals of Pittsburgh Monroeville, LifeCare Hospitals of P ittsburgh LLC, LifeCare Hospitals of Pittsburgh-Suburban and LifeCare Hospitals of Pittsburgh-Alle-Kiski,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 9, 2019 Category: American Health Authors: Paul J. Gough Source Type: news

Takeda to sell eye drug to Novartis in $5.3bn deal
Japanese drugmaker is looking to reduce its $48bn debt following Shire acquisition (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 9, 2019 Category: Pharmaceuticals Source Type: news

Centene-WellCare executives address employee concerns over $17.3B merger
Executives tried to address employees ’ concerns and questions about the coming $17.3 billion merger. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 7, 2019 Category: American Health Authors: Crystal Owens Source Type: news

WVU Health System's acquisition to make it an integrated financing/delivery network
West Virginia University Health System is taking the first steps toward becoming an integrated health care financing and delivery system with Tuesday's announcement it would merge with a Wheeling, West Virginia-based insurer. Financial terms of the deal between WVU Health System, also known as WVU Medicine, and managed-care provider The Health Plan, weren't disclosed. The Health Plan would become a subsidiary of WVU Health System as a nonprofit corporation. An integrated financing and delivery… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2019 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Humana deal rumors brew (again) as hedge funds consider fighting mega deal
Rumors are again rumbling around Louisville-based health care and insurance company Humana Inc. as two hedge funds mull opposing a health insurance mega-merger. Newswire service Reuters reported Monday that two hedge funds — Corvex Management LP and Sachem Head Capital Management LP — may oppose St. Louis-based Centene Corp.'s proposed $17.3 billion acquisition of Tampa, Fla.-based WellCare Health Plans Inc. Both companies are giants in the commerc ial and government-backed health plan… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2019 Category: Biotechnology Authors: Chris Larson Source Type: news

Centene CEO: We ’re Committed To Buying WellCare
Centene CEO Michael Neidorff is committed to completing the acquisition of WellCare Health Plans with the regulatory process well underway. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 7, 2019 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Source Type: news

How Endologix Renewed One Doctor & #039;s Confidence in the Ovation Device
It's been a turbulent couple of years for Endologix, but as MD+DI reported in February, the company has been working hard to win back customers. During the company's first-quarter earnings call, CEO John Onopchenko shared a story about a physician at an academic medical center in the Western United States (he did not disclose the name of the physician or the center) who had used Ovation only twice over the course of 2017 and 2018.  Irvine, CA-based Endologix acquired the Ovation platform through its merger with TriVascular in February 2016. It's a low-profile device that has broadened the company's portfolio in...
Source: MDDI - May 7, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Fresenius Medical Care North America Announces Leadership Additions Following NxStage Merger
New Leadership and Team to Further Company's Commitment to Home Therapies WALTHAM, Mass., May 6, 2019 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and s... Devices, Personnel Fresenius, NxStage Medical, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 6, 2019 Category: Pharmaceuticals Source Type: news

Centene-WellCare deal scrutinized by American Hospital Association
The American Hospital Association is asking the U.S. Department of Justice to investigate the planned $17.3 billion acquisition of Tampa-based WellCare Health Plans by Clayton-based Centene Corp., saying the transaction threatens to reduce competition. In an April 30 letter to the assistant U.S. attorney general’s AntiTrust Division, the association urged the investigation because the merger is “likely to reduce competition in the provision of Medicaid Services.” Centene Corp. announced… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 6, 2019 Category: American Health Authors: Crystal Owens Source Type: news

WellCare-Centene acquisition scrutinized by American Hospital Association
The American Hospital Association is asking the U.S. Department of Justice to investigate the proposed $17.3 billion acquisition of Tampa-based WellCare Health Plans by Centene Corp., saying the transaction threatens to reduce competition. In an April 30 letter to the Assistant U.S. Attorney General’s AntiTrust Division, the association urged the investigation because the merger is “likely to reduce competition in the provision of Medicaid Services.” Centene Corp. of St. Louis announced… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 6, 2019 Category: American Health Authors: Crystal Owens Source Type: news